AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX)

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / SPONSORED ADR
Total 13F shares
2,646,851
Share change
+2,646,851
Total reported value
$63,512,000
Price per share
$24.00
Number of holders
14
Value change
+$63,512,000
Number of buys
14

Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q3 2015

As of 30 Sep 2015, AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,646,851 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, VHCP Management, LLC, BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, LLC, EcoR1 Capital, LLC, MILLENNIUM MANAGEMENT LLC, TURNER INVESTMENTS, L.P., Cormorant Asset Management, LLC, NEA Management Company, LLC, and DAFNA Capital Management LLC. This page lists 14 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.